Aravax
Revolutionising the treatment of food allergy.
$42M Series B+ ·
Source: startupintros.com
Total raised: $62M across 2 sourced rounds
All 2 rounds ↓Signals
Website registeredJan 15, 2016 (10 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $42M | — | startupintros.com | |
| Series B+ | $20M | fundraisingfox.com |
Timeline
- Website created
Founders and team
RO
Robyn O'Hehir FounderSP
Sara Prickett FounderPH
Pascal Hickey Chief Executive Officer
Investors
- AAgati Capital
BBrandon Capitallead investor
BBreakthrough Victoria
MMedical Research Commercialisation Fund (MRCF)
NNovartis Venture Fund
TTenmilelead investor
UUniseed
UUniSuper
Similar Health and bio companies
OOmni Pet$14.6M Series A · Jul 2026
AAllermi$3.5M Seed · Mar 2023
VVumedi$140M Series B+ · Nov 2026
NNeurosterix$105M Series B+ · Nov 2026
OOSMUNDA$14.99M Series B+ · Nov 2026
BBoston Medical Sciences$34.69M Series B+ · Nov 2026
Other companies backed by Brandon Capital
AAdvanCell$315M Series B+ · Jul 2026
NNRG Therapeutics$67M Series B+ · Sep 2025
CCatalYm$150M Series B+ · Jul 2024
MMyricx Bio$120M Series A · Jul 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/aravax (get a free API key).